Top Markets
Coin of the day
Health-Chem Corporation Health-Chem Corporation

Health-Chem Corporation

HCLC
Clasificación en acciones #40840
Health-Chem Corporation, operating through its subsidiary, Transderm... Health-Chem Corporation, operating through its subsidiary, Transderm Laboratories Corporation, specializes in the research, development, manufacturing, and commercialization of transdermal drug delivery systems throughout the United States. Among its key products are transdermal nitroglycerin patches, formulated to provide relief for vascular and cardiovascular symptoms linked to angina pectoris (commonly known as chest pain) via skin absorption. The company additionally offers contract research and development services to third-party clients. Health-Chem Corporation employs a multifaceted sales strategy, directly engaging with wholesalers, distributors, prominent retail pharmacy chains, mail-order pharmacies, and group purchasing organizations. Its products also reach the market indirectly through independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management firms. Founded in 1970, the company's headquarters are situated in Emigsville, Pennsylvania.
Precio por acción
$0.0001
Última sincronización: 2025-01-02
Capitalización bursátil
$73.99K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Health-Chem Corporation (HCLC)

Categoría

Ganancias de Health-Chem Corporation (HCLC)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Health-Chem Corporation, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Health-Chem Corporation desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US